Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study

Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contra...

Full description

Saved in:
Bibliographic Details
Published inAllergy Vol. 64; no. 2; pp. 234 - 241
Main Authors Brockow, K, Romano, A, Aberer, W, Bircher, A.J, Barbaud, A, Bonadonna, P, Faria, E, Kanny, G, Lerch, M, Pichler, W.J, Ring, J, Rodrigues Cernadas, J, Tomaz, E, Demoly, P, Christiansen, C
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.02.2009
Blackwell Publishing Ltd
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
AbstractList Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Methods: Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Results: Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. Conclusions: These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors. [PUBLICATION ABSTRACT]
Background:Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions.Methods:Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls.Results:Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure.Conclusions:These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
Background:  Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Methods:  Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy‐one never‐exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Results:  Skin test specificity was 96–100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross‐reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. Conclusions:  These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
Background:  Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Methods:  Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy‐one never‐exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Results:  Skin test specificity was 96–100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross‐reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. Conclusions:  These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions.BACKGROUNDIodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions.Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls.METHODSSkin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls.Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure.RESULTSSkin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure.These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.CONCLUSIONSThese data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity and sensitivity of skin tests in patients who have experienced such reactions. Skin prick, intradermal and patch tests with a series of contrast media were conducted in 220 patients with either immediate or nonimmediate reaction. Positive skin tests were defined according to internationally accepted guidelines. Seventy-one never-exposed subjects and 11 subjects who had tolerated contrast medium exposure, served as negative controls. Skin test specificity was 96-100%. For tests conducted within the time period from 2 to 6 months after the reaction, up to 50% of immediate reactors and up to 47% of nonimmediate reactors were skin test positive. For immediate reactors, the intradermal tests were the most sensitive, whereas delayed intradermal tests in combination with patch tests were needed for optimal sensitivity in nonimmediate reactors. Contrast medium cross-reactivity was more common in the nonimmediate than in the immediate group. Interestingly, 49% of immediate and 52% of nonimmediate symptoms occurred in previously unexposed patients. Many of these patients were skin test positive, indicating that they were already sensitized at the time of first contrast medium exposure. These data suggest that at least 50% of hypersensitivity reactions to contrast media are caused by an immunological mechanism. Skin testing appears to be a useful tool for diagnosis of contrast medium allergy and may play an important role in selection of a safe product in previous reactors.
Author Lerch, M
Tomaz, E
Barbaud, A
Romano, A
Faria, E
Bonadonna, P
Ring, J
Demoly, P
Bircher, A.J
Brockow, K
Pichler, W.J
Aberer, W
Christiansen, C
Rodrigues Cernadas, J
Kanny, G
Author_xml – sequence: 1
  fullname: Brockow, K
– sequence: 2
  fullname: Romano, A
– sequence: 3
  fullname: Aberer, W
– sequence: 4
  fullname: Bircher, A.J
– sequence: 5
  fullname: Barbaud, A
– sequence: 6
  fullname: Bonadonna, P
– sequence: 7
  fullname: Faria, E
– sequence: 8
  fullname: Kanny, G
– sequence: 9
  fullname: Lerch, M
– sequence: 10
  fullname: Pichler, W.J
– sequence: 11
  fullname: Ring, J
– sequence: 12
  fullname: Rodrigues Cernadas, J
– sequence: 13
  fullname: Tomaz, E
– sequence: 14
  fullname: Demoly, P
– sequence: 15
  fullname: Christiansen, C
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21059512$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19178403$$D View this record in MEDLINE/PubMed
BookMark eNqNks1uEzEUhS1URNPCK4CFRHcT_Dcz9gKkqmoBKRKL0rXlce60DhM72B7avD0eErLoJnhjS_7Ote895wyd-OABIUzJnJb1cTWnXMlKKVXPGSFyTqjkbP70As0OFydoRiipK1FzeYrOUloRQlqmyCt0ShVtpSB8htLtT-dxhpSdv8fluDHZgc8JP7r8gB-2G4gJfHLZ_XZ5iyMYm13wCeeAXVg6bzIssQ0-R5MyXsPSGVxhg6_HGDZgPF6PQ3a21ISIUx6X29foZW-GBG_2-zm6u7n-cfW1Wnz_8u3qclHZuiGs4kL0qm87S82yk4JK2lrBgRtay6YDJZveAAcmOtmzDmSnClVDgSzjbSf5ObrY1d3E8GssLeq1SxaGwXgIY9JNIxtCa34UFA3lvGbkKMiIILStVQHfPwNXYYy-dKupaqQSVEzPvt1DY1fmpjfRrU3c6n_uFODDHjDJmqGPxluXDhwr9qqassJ93nE2hpQi9Nq6bCabiilu0JToKTZ6pad06CkdeoqN_hsb_VQKyGcFDn85Lv20kz66Abb_rdOXi8V0Kvp3O31vgjb3sfR3d8sI5cWZMgTV8j8UcONQ
CODEN LLRGDY
CitedBy_id crossref_primary_10_1016_S1877_0320_09_72483_2
crossref_primary_10_1016_S1959_5182_12_58698_8
crossref_primary_10_1111_j_1365_2133_2011_10623_x
crossref_primary_10_1259_bjr_20220494
crossref_primary_10_1016_j_iac_2014_04_002
crossref_primary_10_1111_all_12589
crossref_primary_10_32902_2663_0338_2020_3_43_51
crossref_primary_10_1016_j_jpp_2019_07_004
crossref_primary_10_1186_s12948_020_00128_3
crossref_primary_10_3390_diagnostics14020123
crossref_primary_10_51620_0869_2084_2021_66_12_747_754
crossref_primary_10_1016_j_waojou_2021_100561
crossref_primary_10_1016_j_jaip_2020_12_057
crossref_primary_10_1016_j_jaip_2023_10_040
crossref_primary_10_3346_jkms_2015_30_3_245
crossref_primary_10_1016_j_anai_2017_08_014
crossref_primary_10_1007_s00108_008_2210_0
crossref_primary_10_1097_ACI_0000000000000282
crossref_primary_10_1016_j_crad_2010_11_006
crossref_primary_10_1111_all_12350
crossref_primary_10_1007_s00330_024_10872_8
crossref_primary_10_1177_1538574417736420
crossref_primary_10_3390_ijms241612577
crossref_primary_10_1016_j_iac_2014_04_013
crossref_primary_10_1111_all_14656
crossref_primary_10_1016_j_jaip_2022_12_048
crossref_primary_10_1016_j_iac_2021_12_001
crossref_primary_10_1016_j_jdcr_2020_08_006
crossref_primary_10_1097_ACI_0000000000001001
crossref_primary_10_1111_cod_14654
crossref_primary_10_1016_j_mcna_2010_03_007
crossref_primary_10_2214_AJR_19_21547
crossref_primary_10_1016_j_iac_2023_04_002
crossref_primary_10_1016_j_rx_2024_03_011
crossref_primary_10_1016_j_ancard_2012_09_007
crossref_primary_10_1016_j_annder_2010_01_005
crossref_primary_10_2174_1381612829666221025091827
crossref_primary_10_1016_j_iac_2009_04_003
crossref_primary_10_1016_j_iac_2009_04_001
crossref_primary_10_1016_j_reval_2017_05_002
crossref_primary_10_1007_s40521_019_00226_x
crossref_primary_10_1016_j_iac_2009_04_008
crossref_primary_10_1016_j_heliyon_2021_e08401
crossref_primary_10_1016_j_anai_2013_01_004
crossref_primary_10_3348_kjr_2018_19_2_352
crossref_primary_10_1093_ced_llae294
crossref_primary_10_1016_j_jaip_2021_04_006
crossref_primary_10_1016_S0025_6196_11_60756_8
crossref_primary_10_1097_ACI_0000000000000285
crossref_primary_10_1111_j_1365_2222_2010_03487_x
crossref_primary_10_1111_cod_13790
crossref_primary_10_1177_08465371241311253
crossref_primary_10_1016_j_jaip_2020_11_023
crossref_primary_10_2332_allergolint_12_LE_0455
crossref_primary_10_1016_j_legalmed_2016_11_006
crossref_primary_10_1148_radiol_222467
crossref_primary_10_1016_j_jaip_2019_04_036
crossref_primary_10_1016_j_jacr_2014_09_032
crossref_primary_10_1016_j_ejrad_2010_12_049
crossref_primary_10_1136_rapm_2019_100911
crossref_primary_10_3389_fphar_2016_00171
crossref_primary_10_1016_j_nefroe_2021_05_009
crossref_primary_10_3390_medicina58040517
crossref_primary_10_1007_s15007_017_1327_7
crossref_primary_10_1016_j_iac_2014_01_014
crossref_primary_10_1007_s40521_018_0154_8
crossref_primary_10_1016_j_mcna_2010_03_006
crossref_primary_10_1097_MOO_0b013e32833ad4c9
crossref_primary_10_1007_s40261_013_0055_3
crossref_primary_10_1016_j_annfar_2011_01_001
crossref_primary_10_1016_j_anai_2016_07_010
crossref_primary_10_1016_j_jaip_2019_04_005
crossref_primary_10_1177_0310057X1704500504
crossref_primary_10_4065_84_7_663_a
crossref_primary_10_1016_j_iac_2022_01_003
crossref_primary_10_1016_j_reval_2016_01_040
crossref_primary_10_1111_j_1365_2222_2010_03693_x
crossref_primary_10_2174_1574886316666210923143012
crossref_primary_10_1002_ccd_28618
crossref_primary_10_1016_j_ejrad_2021_110101
crossref_primary_10_1016_j_rxeng_2024_03_012
crossref_primary_10_1136_rapm_2018_000012
crossref_primary_10_1186_1710_1492_9_12
crossref_primary_10_36691_RJA551
crossref_primary_10_3390_biomedicines10051036
crossref_primary_10_1016_j_reval_2011_01_034
crossref_primary_10_1111_cod_14063
crossref_primary_10_1016_S0098_1672_09_79046_0
crossref_primary_10_4161_onci_26333
crossref_primary_10_1016_j_anai_2010_12_020
crossref_primary_10_1177_1538574418765386
crossref_primary_10_25259_JCIS_47_2024
crossref_primary_10_1007_s00105_013_2695_x
crossref_primary_10_1371_journal_pone_0100154
crossref_primary_10_1016_j_jaip_2019_08_001
crossref_primary_10_1177_02841851251321476
crossref_primary_10_1055_a_1581_1663
crossref_primary_10_1111_j_1365_2222_2009_03425_x
crossref_primary_10_1111_all_15433
crossref_primary_10_1007_s40521_019_00224_z
crossref_primary_10_1097_ACI_0b013e3283312f84
crossref_primary_10_1097_ACI_0b013e32833e0896
crossref_primary_10_1016_j_jaci_2015_07_035
crossref_primary_10_1016_j_jaip_2024_10_039
crossref_primary_10_1586_ecp_10_32
crossref_primary_10_1111_all_12168
crossref_primary_10_1016_j_reval_2011_05_008
crossref_primary_10_1016_j_mayocp_2012_01_012
crossref_primary_10_4168_aard_2014_2_5_352
crossref_primary_10_4168_aard_2018_6_5_270
crossref_primary_10_1148_radiol_2019190829
crossref_primary_10_3233_JRS_230021
crossref_primary_10_1016_j_jaip_2020_01_014
crossref_primary_10_1097_ACI_0b013e32834877c3
crossref_primary_10_1016_j_jaci_2018_10_063
crossref_primary_10_1111_jdv_16139
crossref_primary_10_4168_aard_2016_4_6_442
crossref_primary_10_1080_00325481_2017_1282296
crossref_primary_10_23736_S0392_0488_20_06698_5
crossref_primary_10_4168_aard_2020_8_3_107
crossref_primary_10_1186_s12890_024_02993_z
crossref_primary_10_1016_j_jaci_2011_05_034
crossref_primary_10_1248_bpb_b14_00346
crossref_primary_10_1007_s13341_014_0478_3
crossref_primary_10_1016_j_mcna_2010_04_003
crossref_primary_10_1016_j_jaip_2023_12_005
crossref_primary_10_12793_jkscpt_2012_20_2_165
crossref_primary_10_1002_pds_1650
crossref_primary_10_1111_all_12617
crossref_primary_10_1097_ACI_0000000000000411
crossref_primary_10_1111_j_1398_9995_2011_02554_x
crossref_primary_10_1111_cod_13981
crossref_primary_10_1016_j_chemosphere_2017_11_154
crossref_primary_10_1080_23744235_2021_2009129
crossref_primary_10_1097_ACI_0b013e328362b926
crossref_primary_10_1016_j_ajo_2016_07_010
crossref_primary_10_1016_j_eclinm_2018_07_002
crossref_primary_10_1097_ACI_0b013e3283489ae5
crossref_primary_10_1177_20587384211015061
crossref_primary_10_1111_all_13715
crossref_primary_10_1016_j_waojou_2022_100680
crossref_primary_10_1097_ACI_0000000000000548
crossref_primary_10_1007_s11882_012_0324_x
crossref_primary_10_1016_j_annder_2016_06_004
crossref_primary_10_1016_j_jaip_2014_07_015
crossref_primary_10_1097_ACI_0b013e32833f1ba6
crossref_primary_10_3389_fimmu_2017_00614
crossref_primary_10_1016_j_medleg_2012_04_001
crossref_primary_10_1016_j_jaip_2020_08_006
crossref_primary_10_3390_biomedicines10040759
crossref_primary_10_3389_fphar_2020_575437
crossref_primary_10_1016_j_anai_2012_01_012
crossref_primary_10_1016_j_jaci_2009_12_981
crossref_primary_10_1111_all_13603
crossref_primary_10_1186_s12948_018_0097_4
crossref_primary_10_1111_cea_12591
crossref_primary_10_36691_RJA661
crossref_primary_10_1111_cod_14372
crossref_primary_10_1111_all_14147
crossref_primary_10_1016_j_anai_2019_11_022
crossref_primary_10_1515_pthp_2018_0023
crossref_primary_10_4168_aair_2022_14_4_348
crossref_primary_10_1111_all_12886
crossref_primary_10_1089_jop_2011_0221
crossref_primary_10_1111_j_1398_9995_2012_02840_x
crossref_primary_10_1016_j_jaci_2012_04_050
crossref_primary_10_1111_ced_13990
crossref_primary_10_1111_ced_13991
crossref_primary_10_12793_tcp_2021_29_e10
crossref_primary_10_1016_j_jaci_2012_04_051
crossref_primary_10_1016_j_jbi_2010_02_003
crossref_primary_10_1016_j_reval_2010_01_036
crossref_primary_10_1016_j_iccl_2014_03_004
crossref_primary_10_4168_aard_2014_2_5_315
crossref_primary_10_1016_j_ejrad_2025_111939
crossref_primary_10_1016_j_iac_2014_03_002
crossref_primary_10_1016_j_ejrex_2010_03_003
crossref_primary_10_1007_s00105_012_2372_5
crossref_primary_10_1016_j_jaip_2023_07_004
crossref_primary_10_5124_jkma_2012_55_8_779
crossref_primary_10_1016_j_anai_2014_07_016
crossref_primary_10_1016_j_lpm_2014_12_008
crossref_primary_10_1016_j_ejrad_2009_09_019
crossref_primary_10_1016_j_anai_2015_07_019
crossref_primary_10_1007_s00330_011_2200_9
crossref_primary_10_1016_j_anai_2013_09_023
crossref_primary_10_1111_j_1365_2125_2010_03764_x
crossref_primary_10_4168_aard_2015_3_6_449
crossref_primary_10_1259_bjr_20180107
crossref_primary_10_1586_eci_11_14
crossref_primary_10_1002_cmmi_331
crossref_primary_10_1007_s40521_021_00287_x
crossref_primary_10_1213_ANE_0000000000005443
crossref_primary_10_1016_j_jaci_2011_08_042
crossref_primary_10_1016_j_nefro_2021_05_008
crossref_primary_10_36691_RJA278
crossref_primary_10_5124_jkma_2020_63_3_155
crossref_primary_10_1007_s11882_014_0442_8
crossref_primary_10_1053_j_trap_2015_01_010
crossref_primary_10_1007_s10555_013_9447_3
crossref_primary_10_1016_j_reval_2015_01_039
crossref_primary_10_1002_ccd_24767
crossref_primary_10_1111_j_1398_9995_2008_01960_x
crossref_primary_10_1016_j_iccl_2020_02_002
crossref_primary_10_1016_j_jaci_2011_08_043
crossref_primary_10_1016_j_jaip_2013_12_001
crossref_primary_10_1016_j_jaip_2018_01_014
crossref_primary_10_1111_all_14061
crossref_primary_10_1111_cod_13242
crossref_primary_10_1111_j_1365_2222_2009_03361_x
crossref_primary_10_1016_j_jacr_2016_10_017
crossref_primary_10_1016_j_jaip_2018_06_030
crossref_primary_10_1259_bjr_83_991_633
crossref_primary_10_3390_diagnostics12071673
crossref_primary_10_1111_j_1600_0536_2010_01816_x
crossref_primary_10_1111_all_12323
crossref_primary_10_1111_cea_12703
crossref_primary_10_36691_RJA626
crossref_primary_10_1016_j_jaci_2009_10_028
crossref_primary_10_1016_j_iac_2015_01_008
crossref_primary_10_3389_fvets_2020_00447
crossref_primary_10_1016_j_jaip_2017_03_016
crossref_primary_10_1016_j_jaip_2022_03_030
crossref_primary_10_1097_RMR_0000000000000109
crossref_primary_10_1016_j_jim_2020_112745
crossref_primary_10_1007_s11547_016_0646_1
crossref_primary_10_1016_j_jaip_2017_10_040
crossref_primary_10_1111_j_1398_9995_2009_02137_x
crossref_primary_10_1016_j_anai_2019_12_030
crossref_primary_10_1259_bjr_23957418
crossref_primary_10_1586_1744666X_2013_828871
crossref_primary_10_1016_S0716_8640_11_70425_4
crossref_primary_10_1111_all_12214
crossref_primary_10_1177_0284185114568049
crossref_primary_10_3390_physiologia2030006
crossref_primary_10_1016_j_ejrad_2010_06_014
crossref_primary_10_1016_j_aller_2013_01_002
crossref_primary_10_1111_j_1365_2222_2010_03493_x
crossref_primary_10_1007_s00330_019_06138_3
crossref_primary_10_1007_s40521_017_0130_8
Cites_doi 10.1111/j.1398-9995.2005.00745.x
10.1016/j.tox.2004.12.020
10.1016/S0091-6749(99)70197-1
10.1007/s00330-002-1620-y
10.1111/j.1398-9995.1998.tb03832.x
10.1136/emj.13.2.114
10.1111/j.1398-9995.2001.00002.x-i1
10.1016/j.tox.2004.12.032
10.1016/j.jaci.2004.09.012
10.1034/j.1398-9995.2001.056003250.x
10.1148/radiol.2251011654
10.1016/S0091-6749(99)70439-2
10.1159/000096920
10.1034/j.1398-9995.1999.00247.x
10.1016/j.jaci.2007.02.007
10.1002/cmmi.63
10.1148/radiology.175.3.2343107
10.1111/j.1365-2222.2006.02532.x
10.1016/S0335-7457(01)00130-7
10.1002/pds.822
10.1111/j.0105-1873.2004.00367.x
10.1148/radiology.209.1.9769830
10.1034/j.1600-0536.2001.450601.x
10.7326/0003-4819-140-12-200406150-00009
10.1016/S0140-6736(77)91953-5
10.1007/s00330-006-0202-9
ContentType Journal Article
Copyright 2009 The Authors. Journal compilation © 2009 Blackwell Munksgaard
2009 INIST-CNRS
Journal compilation © 2009 Blackwell Munksgaard
Copyright_xml – notice: 2009 The Authors. Journal compilation © 2009 Blackwell Munksgaard
– notice: 2009 INIST-CNRS
– notice: Journal compilation © 2009 Blackwell Munksgaard
CorporateAuthor for the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity
European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity
CorporateAuthor_xml – name: for the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity
– name: European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity
DBID FBQ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7S9
L.6
7X8
DOI 10.1111/j.1398-9995.2008.01832.x
DatabaseName AGRIS
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts
CrossRef

MEDLINE - Academic
AGRICOLA
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1398-9995
0108-1675
EndPage 241
ExternalDocumentID 1631373861
19178403
21059512
10_1111_j_1398_9995_2008_01832_x
ALL1832
US201301584097
Genre article
Multicenter Study
Journal Article
GeographicLocations Europe
GroupedDBID .3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAVGM
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHUG
ABJNI
ABLJU
ABOCM
ABPTK
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOETA
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FBQ
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TR2
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
Y6R
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
AHBTC
AHEFC
AITYG
ALVPJ
HGLYW
OIG
WIN
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
IQODW
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7S9
L.6
7X8
ID FETCH-LOGICAL-c5602-344f9f7bc1adb841817c43e3a1586be986fae3e24b8f2be8b9b845e7c4c237b83
IEDL.DBID DR2
ISSN 0105-4538
1398-9995
IngestDate Fri Jul 11 06:46:00 EDT 2025
Fri Jul 11 00:14:39 EDT 2025
Fri Jul 11 15:16:49 EDT 2025
Sun Jul 13 04:34:17 EDT 2025
Mon Jul 21 05:45:55 EDT 2025
Wed Apr 02 07:25:37 EDT 2025
Thu Apr 24 23:10:15 EDT 2025
Tue Jul 01 04:14:46 EDT 2025
Wed Jan 22 16:33:31 EST 2025
Wed Dec 27 19:15:19 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Human
skin tests
Immunopathology
Immunology
Dermatology
Multicenter study
Hypersensitivity
Exploration
Radioopaque marker
Contrast media
Iodine
Skin test
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5602-344f9f7bc1adb841817c43e3a1586be986fae3e24b8f2be8b9b845e7c4c237b83
Notes http://dx.doi.org/10.1111/j.1398-9995.2008.01832.x
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2008.01832.x
PMID 19178403
PQID 196894143
PQPubID 34098
PageCount 8
ParticipantIDs proquest_miscellaneous_66860153
proquest_miscellaneous_46133520
proquest_miscellaneous_20401759
proquest_journals_196894143
pubmed_primary_19178403
pascalfrancis_primary_21059512
crossref_citationtrail_10_1111_j_1398_9995_2008_01832_x
crossref_primary_10_1111_j_1398_9995_2008_01832_x
wiley_primary_10_1111_j_1398_9995_2008_01832_x_ALL1832
fao_agris_US201301584097
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2009
PublicationDateYYYYMMDD 2009-02-01
PublicationDate_xml – month: 02
  year: 2009
  text: February 2009
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: Denmark
– name: Zurich
PublicationTitle Allergy
PublicationTitleAlternate Allergy
PublicationYear 2009
Publisher Oxford, UK : Blackwell Publishing Ltd
Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Oxford, UK : Blackwell Publishing Ltd
– name: Blackwell Publishing Ltd
– name: Blackwell
References 1993; 25
2008; 190
2000; 47
2006; 16
2002; 12
2005; 115
2004; 140
2006; 36
2007
1999; 103
2006; 1
2005; 60
2001; 45
1996; 13
2003; 12
2007; 214
2004; 50
2000; 18
2007; 119
2002; 42
2001; 6
2002; 225
1977; 1
1998; 209
2005; 209
1999; 54
1999; 31
2005; 15
2001; 56
2005; 17
1998; 53
1990; 175
Christiansen C (e_1_2_6_2_2) 2007
e_1_2_6_18_2
Christiansen C (e_1_2_6_11_2) 2002; 12
e_1_2_6_19_2
e_1_2_6_35_2
e_1_2_6_13_2
e_1_2_6_10_2
e_1_2_6_33_2
Brockow K (e_1_2_6_12_2) 1999; 31
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
Gomes ER (e_1_2_6_32_2) 2005; 17
e_1_2_6_20_2
Trcka J (e_1_2_6_30_2) 2008; 190
Guillen Toledo J (e_1_2_6_23_2) 2000; 47
Kanny G (e_1_2_6_34_2) 1993; 25
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
Hosoya T (e_1_2_6_25_2) 2000; 18
e_1_2_6_5_2
e_1_2_6_24_2
Mertes PM (e_1_2_6_31_2) 2005; 15
e_1_2_6_22_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
e_1_2_6_26_2
References_xml – volume: 214
  start-page: 89
  year: 2007
  end-page: 93
  article-title: Recurrent flexural exanthema (SDRIF or baboon syndrome) after administration of two different iodinated radio contrast media
  publication-title: Dermatology
– volume: 54
  start-page: 999
  year: 1999
  end-page: 1003
  article-title: Drug hypersensitivity: questionnaire
  publication-title: Allergy
– volume: 13
  start-page: 114
  year: 1996
  end-page: 115
  article-title: Patients’ knowledge about their drug allergies
  publication-title: J Accid Emerg Med
– volume: 15
  start-page: 91
  year: 2005
  end-page: 101
  article-title: Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice
  publication-title: J Investig Allergol Clin Immunol
– volume: 140
  start-page: 1001
  year: 2004
  end-page: 1006
  article-title: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction
  publication-title: Ann Intern Med
– volume: 16
  start-page: 1570
  year: 2006
  end-page: 1579
  article-title: A practical guide to diagnose lesser‐known immediate and delayed contrast media‐induced adverse cutaneous reactions
  publication-title: Eur Radiol
– volume: 6
  start-page: 250
  year: 2001
  end-page: 251
  article-title: Allergy and contrast media
  publication-title: Allergy
– volume: 225
  start-page: 466
  year: 2002
  end-page: 470
  article-title: Effective prophylactic protocol in delayed hypersensitivity to contrast media: report of a case involving lymphocyte transformation studies with different compounds
  publication-title: Radiology
– volume: 50
  start-page: 359
  year: 2004
  end-page: 366
  article-title: Low negative predictive value of skin tests in investigating delayed reactions to radio‐contrast media
  publication-title: Contact Dermatitis
– start-page: 140
  year: 2007
  end-page: 148
– volume: 1
  start-page: 81
  year: 2006
  article-title: Immediate reactions following ICM injection: results of a 3‐year prospective multicenter survey
  publication-title: Contrast Med Mol Imaging
– volume: 45
  start-page: 321
  year: 2001
  end-page: 328
  article-title: Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions
  publication-title: Contact Dermatitis
– volume: 115
  start-page: 179
  year: 2005
  end-page: 185
  article-title: T cell‐mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests
  publication-title: J Allergy Clin Immunol
– volume: 36
  start-page: 1072
  year: 2006
  end-page: 1077
  article-title: Diagnosis of iodinated contrast media hypersensitivity: results of a 6‐year period
  publication-title: Clin Exp Allergy
– volume: 209
  start-page: 189
  year: 2005
  end-page: 192
  article-title: Contrast media hypersensitivity – scope of the problem
  publication-title: Toxicology
– volume: 209
  start-page: 185
  year: 2005
  end-page: 187
  article-title: X‐ray contrast media – an overview
  publication-title: Toxicology
– volume: 31
  start-page: 49
  year: 1999
  end-page: 51
  article-title: Positive skin tests in late reactions to radiographic contrast media
  publication-title: Allerg Immunol (Paris)
– volume: 103
  start-page: 1186
  year: 1999
  end-page: 1190
  article-title: A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins
  publication-title: J Allergy Clin Immunol
– volume: 119
  start-page: 1529
  year: 2007
  end-page: 1536
  article-title: Cross‐reactivity patterns of T cells specific for iodinated contrast media
  publication-title: J Allergy Clin Immunol
– volume: 12
  start-page: S94
  issue: Suppl 4
  year: 2002
  end-page: 97
  article-title: Macular exanthema appearing 5 days after X‐ray contrast medium administration
  publication-title: Eur Radiol
– volume: 60
  start-page: 150
  year: 2005
  end-page: 158
  article-title: Management of hypersensitivity reactions to iodinated contrast media
  publication-title: Allergy
– volume: 103
  start-page: 918
  year: 1999
  end-page: 924
  article-title: Natural evolution of skin test sensitivity in patients allergic to beta‐lactam antibiotics
  publication-title: J Allergy Clin Immunol
– volume: 56
  start-page: 813
  year: 2001
  end-page: 824
  article-title: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
  publication-title: Allergy
– volume: 18
  start-page: 39
  year: 2000
  end-page: 45
  article-title: Delayed adverse reactions to iodinated contrast media and their risk factors
  publication-title: Radiat Med
– volume: 17
  start-page: 1
  year: 2005
  end-page: 10
  article-title: The drug ambassador project. The diversity of diagnostic procedures for drug allergy around Europe
  publication-title: Allergy Clin Immunol Int J World Allergy Org
– volume: 25
  start-page: 425
  year: 1993
  end-page: 430
  article-title: Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE‐mediated reaction
  publication-title: Allerg Immunol (Paris)
– volume: 1
  start-page: 466
  year: 1977
  end-page: 469
  article-title: Incidence and severity of anaphylactoid reactions to colloid volume substitutes
  publication-title: Lancet
– volume: 12
  start-page: 195
  year: 2003
  end-page: 202
  article-title: Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 47
  start-page: 22
  year: 2000
  end-page: 25
  article-title: Anamnesis and skin test to prevent fatal reactions to iodinated contrast media
  publication-title: Rev Alerg Mex
– volume: 53
  start-page: 1133
  year: 1998
  end-page: 1140
  article-title: Detection of IgE antibody to a radiocontrast medium
  publication-title: Allergy
– volume: 42
  start-page: 157
  year: 2002
  end-page: 162
  article-title: Anaphylactic shock with ioxaglate during coronary angiography: Two cases
  publication-title: Rev Fr Allergol Immunol Clin
– volume: 190
  start-page: 666
  year: 2008
  end-page: 670
  article-title: Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE‐mediated allergy?
  publication-title: Am J Radiol
– volume: 209
  start-page: 183
  year: 1998
  end-page: 190
  article-title: Mechanisms of severe, immediate reactions to iodinated contrast material
  publication-title: Radiology
– volume: 175
  start-page: 621
  year: 1990
  end-page: 628
  article-title: Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media
  publication-title: Radiology
– ident: e_1_2_6_21_2
  doi: 10.1111/j.1398-9995.2005.00745.x
– ident: e_1_2_6_6_2
  doi: 10.1016/j.tox.2004.12.020
– ident: e_1_2_6_26_2
  doi: 10.1016/S0091-6749(99)70197-1
– volume: 12
  start-page: S94
  issue: 4
  year: 2002
  ident: e_1_2_6_11_2
  article-title: Macular exanthema appearing 5 days after X‐ray contrast medium administration
  publication-title: Eur Radiol
  doi: 10.1007/s00330-002-1620-y
– ident: e_1_2_6_29_2
  doi: 10.1111/j.1398-9995.1998.tb03832.x
– start-page: 140
  volume-title: Drug hypersensitivity
  year: 2007
  ident: e_1_2_6_2_2
– volume: 190
  start-page: 666
  year: 2008
  ident: e_1_2_6_30_2
  article-title: Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE‐mediated allergy?
  publication-title: Am J Radiol
– ident: e_1_2_6_20_2
  doi: 10.1136/emj.13.2.114
– ident: e_1_2_6_7_2
  doi: 10.1111/j.1398-9995.2001.00002.x-i1
– ident: e_1_2_6_3_2
  doi: 10.1016/j.tox.2004.12.032
– ident: e_1_2_6_10_2
  doi: 10.1016/j.jaci.2004.09.012
– volume: 31
  start-page: 49
  year: 1999
  ident: e_1_2_6_12_2
  article-title: Positive skin tests in late reactions to radiographic contrast media
  publication-title: Allerg Immunol (Paris)
– ident: e_1_2_6_35_2
  doi: 10.1034/j.1398-9995.2001.056003250.x
– ident: e_1_2_6_8_2
  doi: 10.1148/radiol.2251011654
– volume: 47
  start-page: 22
  year: 2000
  ident: e_1_2_6_23_2
  article-title: Anamnesis and skin test to prevent fatal reactions to iodinated contrast media
  publication-title: Rev Alerg Mex
– ident: e_1_2_6_22_2
  doi: 10.1016/S0091-6749(99)70439-2
– volume: 17
  start-page: 1
  year: 2005
  ident: e_1_2_6_32_2
  article-title: The drug ambassador project. The diversity of diagnostic procedures for drug allergy around Europe
  publication-title: Allergy Clin Immunol Int J World Allergy Org
– volume: 18
  start-page: 39
  year: 2000
  ident: e_1_2_6_25_2
  article-title: Delayed adverse reactions to iodinated contrast media and their risk factors
  publication-title: Radiat Med
– ident: e_1_2_6_13_2
  doi: 10.1159/000096920
– ident: e_1_2_6_17_2
  doi: 10.1034/j.1398-9995.1999.00247.x
– ident: e_1_2_6_27_2
  doi: 10.1016/j.jaci.2007.02.007
– ident: e_1_2_6_15_2
  doi: 10.1002/cmmi.63
– ident: e_1_2_6_24_2
  doi: 10.1148/radiology.175.3.2343107
– ident: e_1_2_6_14_2
  doi: 10.1111/j.1365-2222.2006.02532.x
– ident: e_1_2_6_16_2
  doi: 10.1016/S0335-7457(01)00130-7
– ident: e_1_2_6_4_2
  doi: 10.1002/pds.822
– ident: e_1_2_6_9_2
  doi: 10.1111/j.0105-1873.2004.00367.x
– ident: e_1_2_6_28_2
  doi: 10.1148/radiology.209.1.9769830
– ident: e_1_2_6_19_2
  doi: 10.1034/j.1600-0536.2001.450601.x
– volume: 15
  start-page: 91
  year: 2005
  ident: e_1_2_6_31_2
  article-title: Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice
  publication-title: J Investig Allergol Clin Immunol
– ident: e_1_2_6_33_2
  doi: 10.7326/0003-4819-140-12-200406150-00009
– volume: 25
  start-page: 425
  year: 1993
  ident: e_1_2_6_34_2
  article-title: Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE‐mediated reaction
  publication-title: Allerg Immunol (Paris)
– ident: e_1_2_6_18_2
  doi: 10.1016/S0140-6736(77)91953-5
– ident: e_1_2_6_5_2
  doi: 10.1007/s00330-006-0202-9
SSID ssj0007290
ssj0012798
ssj0068258
Score 2.4278965
Snippet Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the specificity...
Background:  Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the...
Background:  Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the...
Background: Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the...
Background:Iodinated contrast media cause both immediate and nonimmediate hypersensitivity reactions. The aim of this prospective study was to determine the...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
fao
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 234
SubjectTerms Adolescent
Adult
adverse effects
Aged
Aged, 80 and over
Allergies
Biological and medical sciences
Child
Contrast Media
Contrast Media - adverse effects
Cross Reactions
Cross Reactions - immunology
diagnosis
Diagnostic tests
diagnostic use
Drug Hypersensitivity
Drug Hypersensitivity - diagnosis
Drug Hypersensitivity - etiology
Drug Hypersensitivity - immunology
etiology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
hypersensitivity
Immunology
Iodine
Iodine - adverse effects
Iodine - immunology
Male
Medical imaging
Medical sciences
Middle Aged
Prospective Studies
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Sensitivity and Specificity
Skin
Skin Tests
Young Adult
Title Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1398-9995.2008.01832.x
https://www.ncbi.nlm.nih.gov/pubmed/19178403
https://www.proquest.com/docview/196894143
https://www.proquest.com/docview/20401759
https://www.proquest.com/docview/46133520
https://www.proquest.com/docview/66860153
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgB8SFb2goFB-4ZtWNndg5VoiqQoUDsFJvlu11CipK0CYrIU78B_4hv4Q3jndLUCtViFuk2Ek8mRm_sZ9nGHspAcqBM5Z5IPgmrWtyW6l5XuCrvZDCKxuzfb6rjhfyzWl5mvhPdBZmzA-xXXAjy4j-mgzcun5q5KKGsdZ1mSiRpJ0zwpNE3SJ89P4ik5RKyy2AE7mEkU9JPZc-aDJT3WxsR7xJ20N0zVjz4jJQOsW4cZI6usvON8MbuSnns_XgZv77X5kf_8_477E7Ccvyw1H57rMboX3Abr1Nu_UP2Zoqe_GB8ni0ZxyXKYlrz2n1l39CCLzqiUA_VrDgwK_xlEXPh45_7jCrAggveWTT237g8ZQL__XjJ7d8s4vAIyOSKKZhxWOu3EdscfT646vjPJV5yD3gVpELKZu6Uc7P7dJpCcihvBRB2HmpKxdqXTU2iFBIp5vCBe1qtCoDGvlCKKfFY7bTdm3YZbxRSh_4EvrlCIlaJzUgVYDPgRtdqiJjavNLjU850KkUxxfzRywEqRqSaqrQSVI13zI23_b8OuYBuUafXWiNsWdw12bxoaBNYoyJMoxlbH-iSttnFoR3AcIytrfRLZO8Sm_gLXUtgXAz9mJ7F-6A9nhsG7p1j_cjYFZlfXULWCedszu4ukVVaYTpJd7yZFTqixEjuMf3404VVfPaojCHJyd09fRfO-6x2-M-HhGJnrGdYbUOzwEHB7cfDf03j8FPvg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELWgSMAFKBQaCq0PXLPqJk7sHCtEtcC2B9qVerPsrFMQVYI2WQlx4h_4Q76EN453S1ArVRW3SLGTeDIzfmOP3zD2RgCUA2fMY0fwTRhbxSaX4zjBV5epSEtpPNvncT6ZiQ9n2VkoB0RnYXp-iPWCG1mG99dk4LQgPbTytIC1FkUWciJJPUcAlPeowLePrz5dcknJsOACQBELmPkwrefKJw3mqruVaShz0rQQXtVXvbgKlg5Rrp-mDh-zi9UA--yUr6NlZ0flj3-4H_-TBJ6wRwHO8oNe_zbZHVc_ZfePwob9M7ak4l68IyqP-pzjMvC4tpwWgPlnRMGLlnLo-yIWHBDWH7RoedfwLw0mVmDhOfcJ9abtuD_own___MUNX20kcJ8USVmmbsE9Xe4Wmx2-O307iUOlh7gE4kriVIiqqKQtx2ZulQDqkKVIXWrGmcqtK1ReGZe6RFhVJdYpW6BV5tCoTFJpVfqcbdRN7bYZr6RU-2UGFbMERo0VCqjKwe3Ak85lEjG5-qe6DDToVI3jQv8VDkGqmqQainSSVPX3iI3XPb_1VCA36LMNtdHmHB5bz04S2ifGmIhkLGK7A11aPzMhyAscFrGdlXLp4FhaDYepCgGQG7G99V14BNrmMbVrli3ej5hZZsX1LWCgdNRu__oWea4QqWd4y4teqy9HjPge3487udfNG4tCH0yndPXyth332IPJ6dFUT98ff9xhD_ttPcoresU2usXSvQY67Oyut_o_ei9T2Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgSBUXvqGh0PrANavdxImdY0VZFVgqBKzUm2VnnYKKkmqTlRAn_gP_kF_CG8e7JaiVKsQtUuwknsyM39jjN4y9EADlwBmL2BF8E8ZWscnlJE7w1WUq0lIaz_Z5nB_NxZuT7CTkP9FZmJ4fYrPgRpbh_TUZ-PmiGhp5WsBYiyILKZGknSPgyVsiHyvS8MMPF1RSMqy3AE_EAlY-zOq59EmDqepmZRpKnDQtZFf1RS8uQ6VDkOtnqelddrYeX5-ccjZadXZUfv-L-vH_COAeuxPALD_ote8-u-HqB2z7Xdiuf8hWVNqLd0TkUZ9yXAYW15bT8i__jBh42VIGfV_CggPA-mMWLe8a_qXBtAokvOA-nd60HffHXPivHz-54ettBO5TIinH1C25J8t9xObTV59eHsWhzkNcAm8lcSpEVVTSlhOzsEoAc8hSpC41k0zl1hUqr4xLXSKsqhLrlC3QKnNoVCaptCp9zLbqpnY7jFdSqnGZQcEsQVFjhQKmcnA68KMLmURMrn-pLgMJOtXi-Kr_CIYgVU1SDSU6Sar6W8Qmm57nPRHINfrsQGu0OYW_1vOPCe0SY0xEMRaxvYEqbZ6ZEOAFCovY7lq3dHArrYa7VIUAxI3Y_uYu_AFt8pjaNasW70fELLPi6hYwTzpoN766RZ4rxOkZ3vKkV-qLESO6x_fjTu5V89qi0AezGV09_deO-2z7_eFUz14fv91lt_s9PUoqesa2uuXKPQc07Oyet_nfSrBSkQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Skin+testing+in+patients+with+hypersensitivity+reactions+to+iodinated+contrast+media+%3A+a+European+multicenter+study&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=BROCKOW%2C+K&rft.au=ROMANO%2C+A&rft.au=RING%2C+J&rft.au=RODRIGUES+CERNADAS%2C+J&rft.date=2009-02-01&rft.pub=Blackwell&rft.issn=0105-4538&rft.volume=64&rft.issue=2&rft.spage=234&rft.epage=241&rft_id=info:doi/10.1111%2Fj.1398-9995.2008.01832.x&rft.externalDBID=n%2Fa&rft.externalDocID=21059512
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon